SeaSpine Holdings Corp. priced its public offering of 6.8 million common shares at $12.50 each.

The Carlsbad, Calif.-based medical technology company also granted underwriters a 30-day option to buy up to an additional 1,020,000 shares at the same price.

Gross proceeds are expected to be about $85 million. SeaSpine plans to use net proceeds for working capital and other general corporate purposes.

The offer is expected to close on or about Jan. 10.

Piper Sandler & Co. and Canaccord Genuity LLC are acting as joint book-running managers, while SunTrust Robinson Humphrey Inc. is acting as lead manager for the offering. BTIG LLC and Ladenburg Thalmann & Co. Inc. are acting as co-managers.

SeaSpine is a medical technology company focused on the design, development and marketing of surgical solutions to treat spinal disorders.